Posted by Michael Wonder on 17 Jan 2018
An open letter to Dr. Scott Gottlieb on FDA transparency
17 January 2018 - Dear Dr. Scott Gottlieb:
Scott, on Tuesday you expressed a desire for the Food and Drug Administration to make public a limited number of complete response letters — the missives the agency sends to drug makers when their marketing applications are rejected. You said these letters could be released if they contain information that might benefit public health.
That’s good, but not good enough.
